Clarus raises $660m for new biotech fund
Clarus Ventures, a Cambridge venture capital firm, has raised $660 million for a sizable new life sciences fund, the company plans to announce today. (Full article: 413 words)
This article is available in our archives:
Globe Subscribers
FREE for subscribers
Subscribers to the Boston Globe get unlimited access to our archives.
Not a subscriber?
Non-Subscribers
Purchase an electronic copy of the full article. Learn More
- $4.95 1 article
- $9.95 4 articles
- $25.95 Monthly
